2016
DOI: 10.1038/nsmb.3285
|View full text |Cite
|
Sign up to set email alerts
|

The pol II CTD: new twists in the tail

Abstract: The C-terminal domain (CTD) of the large subunit of RNA polymerase (pol) II comprises conserved heptad repeats, and post-translational modification of the CTD regulates transcription and cotranscriptional RNA processing. Recently, the spatial patterns of modification of the CTD repeats have been investigated, and new functions of CTD modification have been revealed. In addition, there are new insights into the roles of the enzymes that decorate the CTD. We review these new findings and reassess the role of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
213
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 190 publications
(227 citation statements)
references
References 89 publications
1
213
0
1
Order By: Relevance
“…Early studies of Cdc73 (parafibromin in humans) showed that it interacts directly and stoichiometrically with purified Pol II [2] and is important for Paf1C recruitment [7]. The dynamically modified C-terminal domain (CTD) of Pol II serves as a hub that recruits an array of accessory factors to chromatin [39], and subsequent work showed that a conserved C-terminal domain within Cdc73 preferentially interacts with phosphorylated Pol II CTD peptides in vitro [40, 41]. A second attachment point between Paf1C and the Pol II elongation machinery is mediated by the elongation factor Spt5 [30, 41, 42], which interacts directly with a central region of the Rtf1 subunit [43, 44].…”
Section: Mechanisms Of Targeting Paf1c To Chromatinmentioning
confidence: 99%
“…Early studies of Cdc73 (parafibromin in humans) showed that it interacts directly and stoichiometrically with purified Pol II [2] and is important for Paf1C recruitment [7]. The dynamically modified C-terminal domain (CTD) of Pol II serves as a hub that recruits an array of accessory factors to chromatin [39], and subsequent work showed that a conserved C-terminal domain within Cdc73 preferentially interacts with phosphorylated Pol II CTD peptides in vitro [40, 41]. A second attachment point between Paf1C and the Pol II elongation machinery is mediated by the elongation factor Spt5 [30, 41, 42], which interacts directly with a central region of the Rtf1 subunit [43, 44].…”
Section: Mechanisms Of Targeting Paf1c To Chromatinmentioning
confidence: 99%
“…This unusual and essential domain of Rpb1, the largest component of the 12-subunit polymerase, consists of repeating Y 1 S 2 P 3 T 4 S 5 P 6 S 7 heptapeptides (26 repeats in budding yeast and 52 in humans) (1). The mechanistic consequences of phosphorylating Ser5 and Ser2 have been well documented (2)(3)(4)(5)(6)(7)(8)(9)(10)(11). However, the role of Thr4 phosphorylation (pThr4), and even the necessity of Thr4 for cellular survival, appears to differ among closely related species and between growth conditions within a given species (12)(13)(14)(15).…”
mentioning
confidence: 99%
“…Nevertheless, it is possible that additional kinases may also be able to phosphorylate the PCF11 CID in certain circumstances. For example, this has been shown for Pol II CTD residues, which are often phosphorylated by multiple kinases (Zaborowska et al 2016). We also note that it is likely that WNK1 has additional substrates and potentially other roles in the nucleus, which will be interesting to investigate further.…”
Section: Discussionmentioning
confidence: 99%
“…As Pol II transcribes a gene, the C-terminal domain (CTD) of its largest subunit, which comprises the heptadic repeat structure YSPTSPS (repeated 52 times in the mammalian enzyme, 26 times in yeast), is progressively phosphorylated, in particular at S2 positions (for reviews, see Milligan et al 2016;Zaborowska et al 2016). This phosphorylation mark is then recognized by the cleavage and polyadenylation complex (CPAC), subsequently leading to 3 ′ end processing of the pre-mRNA.…”
mentioning
confidence: 99%